Texas Governor Greg Abbott has until June 22 to sign or veto two significant marijuana-related bills recently approved by the state legislature.

If he takes no action by the deadline, both measures will automatically become law without his signature.

The first bill, House Bill 46, would expand the state’s limited medical marijuana program by adding chronic pain, terminal illness, and traumatic brain injury to the list of qualifying conditions. It would also increase the number of licensed dispensaries from three to fifteen and authorize additional consumption methods such as patches and inhalers.
Continue reading

A bill to legalize medical marijuana in South Carolina has failed to advance this session, but Senator Tom Davis (R) says he’s confident 2026 will be the year it finally passes.

The Compassionate Care Act, sponsored by Senator Tom Davis (R), would have allowed patients with certain medical conditions to access marijuana via licensed dispensaries if recommended by a doctor. Although the legislation has passed the Senate twice, it continues to stall in the House, where Speaker Murrell Smith has said there’s not enough support.

Davis, who has led the charge on medical marijuana reform for over a decade, says he’s more determined than ever to get it done.
Continue reading

Missouri cannabis stores sold $132.81 million worth of legal marijuana in May, according to new data released by the Department of Health and Senior Services.

Mays sales total brings the state’s total sales for 2025 to $628.67 million. May’s numbers represent the highest monthly total so far this year and an over 7% increase over the same month in 2024. Of the $132.81 million, $117.46 million came from recreational marijuana sales, with the remaining $15.35 million from the medical market.

Missouri’s marijuana industry remains strong and continues to trend upward. Adult-use marijuana consistently accounts for close to 90% of monthly sales. Recreational purchases are taxed at a 6% excise rate, plus the state’s 4.2% sales tax and up to 3% local tax, while medical sales are exempt from the excise portion.
Continue reading

The Minnesota Senate has passed legislation that increases the state’s marijuana tax by 50% while eliminating a key revenue-sharing provision with local governments, just months ahead of the official launch of recreational marijuana sales.

Passed in the final hours of a special session Tuesday morning, the legislation raises the marijuana excise tax from 10% to 15%. According to the Tax Foundation, this shift moves Minnesota from one of the lowest marijuana tax rates in the country to one of the highest.

The measure also repeals language requiring 20% of marijuana tax revenue to be distributed to cities and counties. These changes were included in a broader budget deal reached last month by Governor Tim Walz and legislative leaders as the state looks to offset a projected multibillion-dollar deficit in the coming years. A House fiscal analysis projects the changes will bring in over $200 million in new revenue over four years.
Continue reading

Licensed marijuana retailers in Connecticut sold a combined $25,303,044 worth of products in May, marking the state’s highest monthly total so far in 2025.

The Department of Consumer Protection reports that $18,745,365 came from adult-use sales, while medical marijuana accounted for $6,557,679. The increase from April’s total of $23.8 million reflects continued growth in the state’s marijuana market.

The average price per gram dropped to $9.98 in May, the lowest it has been since October 2023. While specific breakdowns by product type were not included, flower and vape cartridges have consistently led monthly sales.
Continue reading

Rhode Island set a new monthly record for marijuana sales in May, surpassing all previous totals since the state launched legal adult-use sales in late 2022.

According to data released by the Department of Business Regulation, licensed marijuana stores sold $10.37 million worth of product in May. That includes $8.68 million from adult-use purchases and $1.69 million in medical marijuana sales.

May’s total exceeds the previous high of $10.25 million set in August 2024 and represents a significant milestone for the state’s growing marijuana industry. The average transaction in May was $34.96, with nearly 300,000 transactions in total.
Continue reading

A federal spending bill that would enact a sweeping ban on hemp-derived THC products is scheduled for a vote in the full House Appropriations Committee on June 11.

Hemp THC gummies.

The proposed ban is part of the Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Bill for fiscal year 2026. It includes language that would redefine hemp under federal law, prohibiting products that contain detectable levels of THC or any cannabinoid marketed for its intoxicating effects. This change would effectively outlaw items such as delta-8 THC, THC-O, smokable hemp flower, and essentially any product with any type of THC derived from hemp.

The bill advanced last week out of the subcommittee overseeing agricultural appropriations in a party-line vote, with nine Republicans voting in favor and seven Democrats opposed. If the full committee approves the measure Tuesday, it will move to the House floor for further consideration.
Continue reading

Infused pre-rolls are taking over California’s marijuana market, now accounting for a commanding majority of all pre-roll sales and driving significant shifts in consumer behavior.

Between December 1, 2024, and February 28, 2025, California’s legal marijuana market generated $1.1 billion in total sales, down slightly—just 0.5%—from the previous period. Of that, pre-rolls brought in $178.1 million, with infused versions making up a dominant 66.3%, according to data from BDSA analyzed by RollPros.

By comparison, non-infused pre-rolls claimed just 33.7% of sales and saw a 2.5% drop in unit sales, underscoring a clear change in what consumers are reaching for on dispensary shelves.

Continue reading

Oklahoma’s medical marijuana patient count has fallen to its lowest level in five years, even as product sales remain strong.

As of June 9, the Oklahoma Medical Marijuana Authority reports 329,170 active patients. That’s the lowest figure recorded since July 2020, when there were just over 313,000 patients. The number also reflects a drop of more than 50,000 from the program’s all-time high of 386,913 in May 2022.

This marks the fifth consecutive monthly decline in patient registrations, continuing a downward trend that began in January 2025, when the count stood at 340,258. The total dipped to 339,529 in February, 337,253 in March, and 336,798 in April before falling more sharply in May and early June.
Continue reading